723 related articles for article (PubMed ID: 22387599)
1. Analysis of serum genome-wide microRNAs for breast cancer detection.
Wu Q; Wang C; Lu Z; Guo L; Ge Q
Clin Chim Acta; 2012 Jul; 413(13-14):1058-65. PubMed ID: 22387599
[TBL] [Abstract][Full Text] [Related]
2. Identification and characterization of novel microRNA candidates from deep sequencing.
Wu Q; Wang C; Guo L; Ge Q; Lu Z
Clin Chim Acta; 2013 Jan; 415():239-44. PubMed ID: 23153516
[TBL] [Abstract][Full Text] [Related]
3. Serum microRNA profiling and breast cancer risk: the use of miR-484/191 as endogenous controls.
Hu Z; Dong J; Wang LE; Ma H; Liu J; Zhao Y; Tang J; Chen X; Dai J; Wei Q; Zhang C; Shen H
Carcinogenesis; 2012 Apr; 33(4):828-34. PubMed ID: 22298638
[TBL] [Abstract][Full Text] [Related]
4. Decreased serum miR-181a is a potential new tool for breast cancer screening.
Guo LJ; Zhang QY
Int J Mol Med; 2012 Sep; 30(3):680-6. PubMed ID: 22692639
[TBL] [Abstract][Full Text] [Related]
5. Serum microRNA profiles serve as novel biomarkers for HBV infection and diagnosis of HBV-positive hepatocarcinoma.
Li LM; Hu ZB; Zhou ZX; Chen X; Liu FY; Zhang JF; Shen HB; Zhang CY; Zen K
Cancer Res; 2010 Dec; 70(23):9798-807. PubMed ID: 21098710
[TBL] [Abstract][Full Text] [Related]
6. Genome-wide microRNA profiles identify miR-378 as a serum biomarker for early detection of gastric cancer.
Liu H; Zhu L; Liu B; Yang L; Meng X; Zhang W; Ma Y; Xiao H
Cancer Lett; 2012 Mar; 316(2):196-203. PubMed ID: 22169097
[TBL] [Abstract][Full Text] [Related]
7. Next-generation sequencing of microRNAs for breast cancer detection.
Wu Q; Lu Z; Li H; Lu J; Guo L; Ge Q
J Biomed Biotechnol; 2011; 2011():597145. PubMed ID: 21716661
[TBL] [Abstract][Full Text] [Related]
8. A circulating miRNA signature as a diagnostic biomarker for non-invasive early detection of breast cancer.
Zhang L; Xu Y; Jin X; Wang Z; Wu Y; Zhao D; Chen G; Li D; Wang X; Cao H; Xie Y; Liang Z
Breast Cancer Res Treat; 2015 Nov; 154(2):423-34. PubMed ID: 26476723
[TBL] [Abstract][Full Text] [Related]
9. Circulating microRNAs as novel minimally invasive biomarkers for breast cancer.
Heneghan HM; Miller N; Lowery AJ; Sweeney KJ; Newell J; Kerin MJ
Ann Surg; 2010 Mar; 251(3):499-505. PubMed ID: 20134314
[TBL] [Abstract][Full Text] [Related]
10. Diagnostic role of microRNA expression profile in the serum of pregnant women with fetuses with neural tube defects.
Gu H; Li H; Zhang L; Luan H; Huang T; Wang L; Fan Y; Zhang Y; Liu X; Wang W; Yuan Z
J Neurochem; 2012 Aug; 122(3):641-9. PubMed ID: 22642222
[TBL] [Abstract][Full Text] [Related]
11. Methylation of a panel of microRNA genes is a novel biomarker for detection of bladder cancer.
Shimizu T; Suzuki H; Nojima M; Kitamura H; Yamamoto E; Maruyama R; Ashida M; Hatahira T; Kai M; Masumori N; Tokino T; Imai K; Tsukamoto T; Toyota M
Eur Urol; 2013 Jun; 63(6):1091-100. PubMed ID: 23200812
[TBL] [Abstract][Full Text] [Related]
12. miRNA profiling reveals a potential role of milk stasis in breast carcinogenesis.
Gu YQ; Gong G; Xu ZL; Wang LY; Fang ML; Zhou H; Xing H; Wang KR; Sun L
Int J Mol Med; 2014 May; 33(5):1243-9. PubMed ID: 24584717
[TBL] [Abstract][Full Text] [Related]
13. Differential expression of microRNAs in plasma of patients with colorectal cancer: a potential marker for colorectal cancer screening.
Ng EK; Chong WW; Jin H; Lam EK; Shin VY; Yu J; Poon TC; Ng SS; Sung JJ
Gut; 2009 Oct; 58(10):1375-81. PubMed ID: 19201770
[TBL] [Abstract][Full Text] [Related]
14. miRNA-34a is associated with docetaxel resistance in human breast cancer cells.
Kastl L; Brown I; Schofield AC
Breast Cancer Res Treat; 2012 Jan; 131(2):445-54. PubMed ID: 21399894
[TBL] [Abstract][Full Text] [Related]
15. MicroRNA miR-21 overexpression in human breast cancer is associated with advanced clinical stage, lymph node metastasis and patient poor prognosis.
Yan LX; Huang XF; Shao Q; Huang MY; Deng L; Wu QL; Zeng YX; Shao JY
RNA; 2008 Nov; 14(11):2348-60. PubMed ID: 18812439
[TBL] [Abstract][Full Text] [Related]
16. Next-generation sequencing identifies novel microRNAs in peripheral blood of lung cancer patients.
Keller A; Backes C; Leidinger P; Kefer N; Boisguerin V; Barbacioru C; Vogel B; Matzas M; Huwer H; Katus HA; Stähler C; Meder B; Meese E
Mol Biosyst; 2011 Dec; 7(12):3187-99. PubMed ID: 22027949
[TBL] [Abstract][Full Text] [Related]
17. miRNA profiling for clear cell renal cell carcinoma: biomarker discovery and identification of potential controls and consequences of miRNA dysregulation.
White NM; Bao TT; Grigull J; Youssef YM; Girgis A; Diamandis M; Fatoohi E; Metias M; Honey RJ; Stewart R; Pace KT; Bjarnason GA; Yousef GM
J Urol; 2011 Sep; 186(3):1077-83. PubMed ID: 21784468
[TBL] [Abstract][Full Text] [Related]
18. A nine-miRNA signature as a potential diagnostic marker for breast carcinoma: An integrated study of 1,110 cases.
Xiong DD; Lv J; Wei KL; Feng ZB; Chen JT; Liu KC; Chen G; Luo DZ
Oncol Rep; 2017 Jun; 37(6):3297-3304. PubMed ID: 28440475
[TBL] [Abstract][Full Text] [Related]
19. Analysis of microRNA expression profiling identifies miR-155 and miR-155* as potential diagnostic markers for active tuberculosis: a preliminary study.
Wu J; Lu C; Diao N; Zhang S; Wang S; Wang F; Gao Y; Chen J; Shao L; Lu J; Zhang X; Weng X; Wang H; Zhang W; Huang Y
Hum Immunol; 2012 Jan; 73(1):31-7. PubMed ID: 22037148
[TBL] [Abstract][Full Text] [Related]
20. miR-218 on the genomic loss region of chromosome 4p15.31 functions as a tumor suppressor in bladder cancer.
Tatarano S; Chiyomaru T; Kawakami K; Enokida H; Yoshino H; Hidaka H; Yamasaki T; Kawahara K; Nishiyama K; Seki N; Nakagawa M
Int J Oncol; 2011 Jul; 39(1):13-21. PubMed ID: 21519788
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]